Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus

Clinical Immunology and Immunopathology

Volumn 80, Issue 1, 1996, Pages 16-22

  Puurunen, Marja ^a   Vaarala, Outi ^a   Julkunen, Heikki ^b   Aho, Kimmo ^a   Palosuo, Timo ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

EID: 0030199628     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0089     Document Type: Article

References (28)

1. 1. Hughes, G. R. V., The antiphospholipid syndrome: Ten years on. Lancet 342, 341-344, 1993.
2. 2. McNeil, H. P., Chesterman, C. N., and Krilis, S. A., Immunology and clinical importance of antiphospholipid antibodies. Adv. Immunol. 49, 193-280, 1991.
3. 3. Sammaritano, L. R., Gharavi, A. E., and Lockshin, M. D., Antiphospholipid antibody syndrome: Immunologic and clinical aspects. Semin. Arthritis Rheum. 20, 81-96, 1990.
4. 4. Vaarala, O., Kleemola, M., Palosuo, T., and Aho, K., Anticardiolipin response in acute infections. Clin. Immunol. Immunopathol. 41, 8-15, 1986.
5. 5. Harris, E. N., Gharavi, A. E., Wasley, G. D., and Hughes, G. R. V., Use of enzyme-linked immunosorbent assay and of inhibition to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders. J. Infect. Dis. 1, 23-31, 1988.
6. 6. Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikaw, K., Sumida, T., Yasuda, T., and Koike, T., Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J. Immunol. 148, 3885-3891, 1992.
7. 7. Hunt, J. E., McNeil, H. P., Morgan, G. J., Crameri, R. M., and Krilis, S. A., A phospholipid beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1, 75-81, 1992.
8. 8. Galli, M., Comforius, P., Maassen, C., Hemker, H. C., De Baets, M. H., van Breda-Vriesman, P. J. C., Barbui, T., Zwaal, R. F. A., and Bevers, E. M., Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet 335, 1544-1547, 1990.
9. 9. McNeil, H. P., Simpson, R. J., Chesterman, C. M., and Krilis, S. A., Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. USA 87, 4120-4124, 1990.
10. 10. Viard, J. P., Amoura, Z., and Bach, J. F., Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am. J. Med. 93(2), 181-186, 1992.
11. 11. Martinuzzo, M. E., Forastiero, R. R., and Carreras, L. O., Anti β2 glycoprotein I antibodies: Detection and association with thrombosis. Br. J. Haematol. 89, 397-402, 1995.
12. 12. Fleck, R. A., Rapaport, S. I., and Rao, L. V., Anti-prothrombin antibodies and the lupus anticoagulant. Blood 72, 512-519, 1988.
13. 13. Bevers, E. M., Galli, M., Barbui, T., Comfurius, P., and Zwaal, R. F. A., Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb. Haemost. 66, 629-632, 1991.
14. 14. Oosting, J. D., Derksen, R. H. W. M., Bobbink, I. W. G., Hackeng, T. M., Bouma, B. N., and De Groot, P. G., Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanism? Blood 81, 2618-2625, 1993.
15. 15. Vaarala, O., Puurunen, M., Mänttäri, M., Manninen, V., Aho, K., and Palosuo, T., Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thromb. Haemost. 75(3), 456-459, 1996.
16. 16. Harris, E. N., Gharavi, A. E., Patel, S., et al. Evaluation of the anticardiolipin antibody test: Report of an international workshop held on 4 April 1986. Clin. Exp. Immunol. 68, 215-222, 1987.
17. 17. Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., McShane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., and Winchester, R. J., The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25, 1271-1277, 1982.
18. 18. Vaarala, O., Binding of anticardiolipin antibodies in sera from patients with SLE and infectious diseases. J. Autoimmun. 4, 819-830, 1991.
19. 19. Triplett, D. A., Coagulation assays for the lupus anticoagulant: Review and critique of current methodology. Stroke 23, 11-14, 1992.
20. 20. Arvieux, J., Roussel, B., Ponard, D., and Colomb, G., IgG2 subclass restriction of anti-β2 glycoprotein 1 antibodies in autoimmune patients. Clin. Exp. Immunol. 95, 310-315, 1994.
21. 21. Permpikul, P., Rao, L. V., and Rapaport, S. I., Functional and binding studies of the roles of prothrombin and beta 2-glycoprotein I in the expression of lupus anticoagulant activity. Blood 83(10), 2878-2892, 1994.
22. 22. Bancsi, L. F. J. M. M., van der Linden, I. K., and Bertina, R. M., β2-glycoprotein I deficiency and the risk of thrombosis. Thromb. Haemost. 67, 649-653, 1992.
23. 23. Schousboe, I., β2-Glycoprotein I: A plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 66, 1086, 1985.
24. 24. Hanson, S. R., Griffith, H. J., Harker, L. A., Kelly, A. B., Esmon, C. T., and Gruber, A., Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J. Clin. Invest. 92, 2003-2012, 1993.
25. 25. Matsuura, E., Igarashi, Y., Yasuda, T., Triplett, D. A., and Koike, T., Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J. Exp. Med. 179, 457-462, 1994.
26. 26. Roubey, R. A. S., Eisenberg, R. A., and Winfield, J. B., "Anticardiolipin" autoantibodies recognize β2-glycoprotein I in the absence of phospholipid. Importance of antigen density and bivalent binding. J. Immunol. 154, 954-960, 1995.
27. 27. Matsuda, J., Saitoh, N., Gohchi, K., Gotoh, M, and Tsukamoto, M., Distinguishing β2-glycoprotein I dependent (systemic lupus erythematosus type) and independent (syphilis type) anticardiolipin antibody with Tween 20. Br. J. Haematol. 85, 799-802, 1993.
28. 28. Bevers, E. M., Comfurius, P., and Zwaal, R. F. A., Changes in membrane phospholipid distribution during platelet activation. Biochim. Biophys. Acta 736, 57-66, 1983.